Introduction: Chemotherapy is a rare cause of iatrogenic vocal fold dysfunction. It has been
reported in three main classes of chemotherapy agents and often occurs during the …

Introduction Unilateral vocal cord paralysis is common than bilateral palsy and is mostly
idiopathic in origin. Other causes may include malignancy, secondary to neck or recurrent …

Background Bilateral vocal cord paralysis is uncommon. Most cases occur secondary to
trauma, malignancy, surgery, or intubation. Also, it was reported as a side effect of Vinca …

Described is the first reported case of paclitaxel-induced recurrent laryngeal nerve paralysis
in a patient receiving adjuvant therapy for breast cancer. This rare form of neuropathy was …

Discussion Neuropathy is a common complication of treatment with chemotherapy. Besides
polyneuropathy, mononeuropathies (such as peroneal and femoral neuropathy) and cranial …

Objective: Chemotherapy-induced vocal fold motion impairment (CIVFMI) is a rare
complication of cancer therapy with potential for airway compromise. The objective of this …

Background Vincristine, a type of vinca alkaloid, is widely used in the treatment of various
childhood and adult malignancies. A well-known side effect of vincristine is its neurotoxicity …

Vocal cord paralysis after administration of the chemotherapeutic agent vincristine is a rare
occurrence. Most occurrences are bilateral. Of the 24 cases referenced in this article, 19 are …

Oxaliplatin is a new, third-generation platinum complex. It has a good safety profile
characterized by low hematological-gastrointestinal toxicity. No significant nephro-ototoxicity …

Vincristine-induced vocal cord paralysis is a rare but serious complication. We report 2
patients with acute lymphoblastic leukemia who developed progressive stridor during …